UBS Group
GDNR

UBS Group’s Gardiner Healthcare Acquisitions Corp. Common Stock GDNR Stock Holding History

UBS Group’s Portfolio GDNR Stock Details GDNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18
Closed -$195 – 10331
2023
Q3 		$195 Buy
+18
New +$193 ﹤0.01% 8718
2023
Q1 		– Sell
-2,712
Closed -$27.9K – 10942
2022
Q4 		$27.9K Buy
2,712
+1,500
+124% +$15.2K ﹤0.01% 7316
2022
Q3 		$12K Buy
1,212
+700
+137% +$6.98K ﹤0.01% 8221
2022
Q2 		$5K Buy
+512
New +$5.08K ﹤0.01% 8976

UBS Group's GDNR Position: Q4 2023 in Review

UBS Group sold out of Gardiner Healthcare Acquisitions Corp. Common Stock (GDNR) in Q4 2023, closing a stake of 18 shares — an estimated $195 sold.

UBS Group first reported a position in GDNR in Q2 2022 and held it in 4 quarters. The position peaked at $27.9K in Q4 2022. 0 funds tracked by Wall St. Rank hold GDNR as of Q4 2023.

  • UBS Group reported no remaining Gardiner Healthcare Acquisitions Corp. Common Stock position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 18 Gardiner Healthcare Acquisitions Corp. Common Stock shares in Q4 2023, an estimated $195.
  • UBS Group first reported a position in Gardiner Healthcare Acquisitions Corp. Common Stock in Q2 2022 and held it in 4 quarters.
  • UBS Group's Gardiner Healthcare Acquisitions Corp. Common Stock position peaked at $27.9K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Gardiner Healthcare Acquisitions Corp. Common Stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.